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Abstract Annexins are multifunctional intracellular proteins
with Ca2+- and phospholipid-binding properties. Their structures
consist of four conserved repeat domains that form the core and a
diverse N-terminal tail, from which their functional differences
may arise. We searched for cellular proteins that interact with
the N-terminal tail plus domain I of annexin I (ANX1) by using
the yeast two-hybrid method. Screening of a HeLa cell cDNA
library yielded annexin II (ANX2) cDNA. The interaction
between ANX1 and ANX2 also occurred in vitro in a Ca2+-
dependent manner. Mapping of the interaction sites revealed that
interaction between domain I of ANX1 and domain IV of ANX2
was stronger than the other combinations.
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1. Introduction
Annexins (ANXs, also called lipocortins) are a family of
intracellular proteins that bind reversibly to phospholipids
in a Ca2-dependent manner. The structures of ANXs, which
are distinct from the EF-hand family of Ca2-binding pro-
teins, consist of the core domains and the N-terminal tails.
The core domains consist of four repeat domains that share
approximately 50% amino acid similarity between di¡erent
ANXs, and have binding sites for Ca2 ions and phospholi-
pids [1,2]. Each ANX family member contains a speci¢c N-
terminal tail that is not structurally related to the other
ANXs. Various members of the ANX family proteins have
been implicated in a number of di¡erent intracellular proc-
esses including vesicular tra⁄cking [3], membrane fusion dur-
ing exocytosis [4], signal transduction [1], and ion channel
formation [5,6]. The di¡erent ANX genes show cell-speci¢c
expression [1], thereby implying that each ANX performs a
di¡erent biological function. Since the N-terminal tails are not
related to each other, these may impart functional speci¢city.
In fact, the N-terminal tails of ANX1, ANX2 and ANX11 are
involved in the interaction with S100C [7], p11 [8] and calcy-
clin [9], respectively, which are members of the S100 subgroup
of the EF-hand family of Ca2-binding proteins. Both the
interaction of ANX1 with S100C and the interaction of
ANX11 with calcyclin are Ca2-dependent. In contrast, the
ANX2 and p11 interaction is Ca2-independent. ANX1 is
structurally more similar to ANX2 than the other ANXs,
and p11 is structurally more similar to S100C than the other
S100 proteins. Another similarity between ANX1 and ANX2
is that they are both phosphorylated by various kinases such
as tyrosine kinase, epidermal growth factor receptor protein
kinase [10,11], pp60src [12] and protein kinase C [13,14]. The
N-terminal region of ANX1 is the site of selective proteolytic
cleavage [15], and seems to be important for cellular func-
tions.
In this study we searched for the cellular proteins interact-
ing with the N-terminal tail plus domain I of ANX1 using the
yeast two-hybrid system. The bait plasmid contained the fu-
sion gene encoding the LexA DNA-binding domain and ami-
no acids 1^113 of ANX1.
2. Materials and methods
2.1. Construction of bait plasmid for two-hybrid system
pEG202 (developed by Brent and coworkers [16]), which was used
as a vector to express the LexA-ANX11ÿ113 fusion protein, contains
the his3 selectable marker, yeast 2W origin, Escherichia coli pBR ori-
gin, and LexA DNA-binding domain. The ANX1 cDNA fragment
containing amino acids 1^113 was PCR ampli¢ed and cloned into
BamHI-SalI sites of pEG202. The resulting plasmid, named pE-
GLexA-ANX11ÿ113, was used as the bait. Yeast strain EGY48
[MATa, his3, trp1, ura3-52, leu: :pLeu-LexAop6/pSH18-34 (LexAop-
lacZ reporter)] was transformed with the plasmid, and expression of
the fusion protein was identi¢ed by Western blot analysis.
2.2. Two-hybrid screening of human HeLa cell cDNA library
A human HeLa cell cDNA library in the transcription activator
B42 fusion vector pJG4-5 [16] was screened. Plasmid pJG4-5 contains
the TRP1 selectable marker, yeast 2W origin, and E. coli pUC origin.
Expression of the fusion protein in this plasmid is under the control of
GAL1, a galactose-inducible promoter. Yeast strain EGY48/pE-
GLexA-ANX11ÿ113 was transformed with HeLa cell cDNA library
by the lithium acetate method. Transformants were selected for tryp-
tophan prototrophy on synthetic agar medium (Ura3, His3, Trp3)
containing 2% glucose. All of the transformants were pooled and re-
spread on synthetic medium (Ura3, His3, Trp3, Leu3) containing 2%
galactose to induce the introduced DNA. Cells growing on the selec-
tion media were retested on the synthetic medium (Ura3, His3, Trp3,
Leu3) containing 2% galactose (inducing condition) and 2% glucose
(non-inducing condition) to con¢rm the dependence of their growth
on the presence of galactose. Cells growing only on the galactose
media were subjected to further characterization. The selected cells
were also streaked on synthetic medium (Ura3, His3, Trp3) contain-
ing 2% galactose or 2% glucose with 5-bromo-4-chloro-3-indolyl-L-D-
galactoside (X-gal) to test for L-galactosidase activity. The cells ex-
pressing both reporter genes only in the presence of galactose were
¢nally chosen to isolate the plasmids. The isolated plasmids were
transformed into E. coli K12 strain KC8 (pyrF: :Tn5, hsdR,
leuB600, trpC9830, lac D74, strA, gslK, hisB436), and the transform-
ants containing the recombinant cDNAs were selected by their growth
on M9 minimal medium (Thi, His, Ura, Leu, Trp3) containing
ampicillin. The plasmids were then isolated from Trp E. coli trans-
formants and used to con¢rm the selection results and to sequence the
inserted cDNA by using the B42 primer (5P-CC AGC CTC TTG CTG
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AGT GGA GAT G). The LexA-IRS (isoleucyl tRNA synthetase) and
B42-EPRS (glutamyl and prolyl tRNA synthetase) hybrid proteins
were used as a positive control of interaction [17]. Other hybrid pro-
teins (B42-L-tubulin, B42-ribosomal phosphoprotein, LexA-ALG2
(apoptosis-linked gene [18])) were used as negative controls.
2.3. In vitro protein binding of ANX1 and ANX2
Full length ANX2 cDNA was cloned into the maltose-binding pro-
tein (MBP) fusion protein expression vector pMAL-P2X 9 (New Eng-
land BioLabs, USA) to produce pMAL-ANX2. The plasmid was
transformed into E. coli XL-1 Blue, and expression of the fusion
protein was induced by 0.3 mM IPTG. The fusion protein was puri-
¢ed using amylose resin (New England BioLabs, USA), according to
the manufacturer’s directions. ANX1 was in vitro translated from
plasmid pCDNA3-ANX1, which was constructed by inserting full
length ANX1 cDNA into pCDNA3 (Invitrogen, USA), using the
TnT rabbit reticulocyte lysate in vitro transcription-translation system
(Promega, USA). Reactions were performed in the presence of 20 WCi
[35S]methionine (Amersham, UK) to label the protein. Multiple ali-
quots of 50 Wl reactions were performed and pooled after incubation
at 30‡C for 90 min. 20 Wl of the reaction mixture was mixed with
MBP-ANX2 (or MBP for control), and the binding bu¡er (20 mM
Tris-HCl pH 8.0, 30 mM NaCl, 0.1 mM EDTA, 0.1% Triton X-100,
0.4 mM PMSF) was added up to 300 Wl. The reaction mixtures were
incubated on a rotating incubator at 4‡C for 12 h. 20 Wl of amylose
resin beads was added to each reaction mixture, and the reaction
mixtures were incubated for an additional 2 h at 4‡C. Beads were
washed four times in 1 ml of the binding bu¡er and resuspended in
20 Wl of 10 mM maltose. The eluate was separated by 15% SDS-
PAGE, and the labeled protein was visualized by autoradiography.
2.4. Quantitation of interaction
The strength of the interaction between di¡erent domains of ANX1
and ANX2 was determined by measuring the expression level of the
lacZ reporter gene. The L-galactosidase activity was determined ac-
cording to the method previously reported [17]. Yeast cells containing
di¡erent sets of plasmids were cultured in yeast synthetic media con-
taining 2% glucose until they reached mid-log phase. Cell growth was
monitored by the absorbance at 600 nm. The culture broth (0.2 ml)
was taken and mixed with Z bu¡er (0.7 ml) containing 2-mercapto-
ethanol. Chloroform (50 Wl) and 0.1% SDS (50 Wl) were added to the
mixture, and the mixture was vortexed for 30 s. The reaction was
started by adding the substrate o-nitrophenyl L-D-galactopyranoside
(ONPG) (0.16 ml), incubated at 30‡C until the yellow color appeared,
and then stopped by adding 0.4 ml of 1 M Na2CO3. Cell debris was
removed by centrifugation, and the absorbance of the supernatant
was measured at 420 nm. Enzyme activity was also measured by a
¢lter method. Brie£y, the cells grown on the yeast plate were patched
onto a ¢lter paper (Whatman 3MM) and this was submerged into
liquid nitrogen for 10 s to freeze the cells. Then the cells were thawed
at room temperature for 20 min to permeabilize the cell wall and the
¢lter was incubated in the X-gal-containing Z bu¡er until a blue color
appeared. The expression level of the reporter gene LEU2 was deter-
mined by the growth rate of the yeast cells in synthetic media lacking
leucine.
3. Results
3.1. Screening for ANX1 interacting proteins
ANX11ÿ113 interacting proteins were screened from a hu-
man HeLa cell cDNA library in plasmid pJG4-5, a transcrip-
tion activator B42 fusion vector, using pEGLexA-ANX11ÿ113
as the bait (Fig. 1A) as described in Section 2. Approximately
1U106 independent transformants were pooled and respread
on selection media (Ura3, His3, Trp3, Leu3) containing 2%
galactose. Of the many colonies that grew on the selection
plate, 100 colonies were chosen and screened for expression
of the two reporter genes (LEU2 and lacZ). The colonies were
streaked on synthetic medium (Ura3, His3, Trp3) containing
2% galactose or 2% glucose with X-gal to test for L-galacto-
sidase activity. Expression of LEU2 was checked by the
growth rate on synthetic medium lacking leucine. Fifteen col-
onies expressing both reporter genes only in the presence of
galactose were analyzed further using several positive and
negative control plasmids to verify the speci¢city of the inter-
action between the bait and the selected clones. All 15 clones
showed speci¢city. The nucleotide sequences were determined
and used for GenBank search.
3.2. Speci¢c interaction of ANX1 with ANX2
Of the 15 clones, 14 turned out to be di¡erent portions of
ANX2 cDNA, and one was a novel gene. One of the 14
ANX2 cDNA clones encoded amino acids 81^338
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Fig. 1. Schematic representation of the LexA-ANX1/1ÿ113 fusion
protein, which was used as the bait (A), and the B42-ANX281ÿ338
fusion protein obtained from the screening (B). A: The DNA frag-
ment encoding amino acids 1^113 of ANX1 (ANX11ÿ113) was
cloned into the BamHI/SalI sites of plasmid pEG202 [16] to pro-
duce the bait plasmid pEGLexA-ANX11ÿ113. B: The clone was se-
lected from screening of a HeLa cell cDNA library in the B42 fu-
sion vector pJG4-5 [16]. Nucleotide sequencing of the selected clone
revealed an ANX2 cDNA fragment encoding amino acids 81^338
(named pJG-ANX281ÿ338).
Fig. 2. Speci¢c interaction between ANX11ÿ113 and ANX281ÿ338 in
yeast. Yeast strain EGY48 transformed with plasmids expressing
LexA-ANX11ÿ113 and B42-ANX281ÿ338 was grown on synthetic me-
dium (Ura3, His3, Trp3, Leu3) containing 2% galactose to verify
the interaction between the two proteins. Di¡erent combinations of
plasmids expressing LexA or B42 fusion proteins were used as posi-
tive and negative controls. Top right, positive interacting control
(LexA-IRS and B42-EPRS) [17]; top left, LexA-ANX11ÿ113 and
B42-ANX281ÿ338 ; middle right, LexA-ANX11ÿ113 and B42-L-tubu-
lin; middle left, LexA-ANX21ÿ105 and B42-ANX281ÿ338 ; bottom
right, LexA-ANX11ÿ113 and B42-P0 (ribosomal phosphoprotein);
bottom left, LexA-ALG2 and B42-ANX281ÿ338.
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(ANX281ÿ338), which covers a portion of the I and all of
domains II^IV (Fig. 1B). The results indicate that
ANX11ÿ113 interacts with ANX281ÿ338. On the other hand,
ANX11ÿ113 did not interact with L-tubulin or ribosomal phos-
phoprotein. Also ANX281ÿ338 did not interact with ALG-2 or
ANX21ÿ105 (middle left) (Fig. 2). Therefore the interaction
between ANX11ÿ113 and ANX281ÿ338 is speci¢c for each oth-
er.
3.3. In vitro protein-protein interaction
The interaction between ANX1 and ANX2 was further in-
vestigated by using in vitro translated 35S-ANX1 and bacte-
rially expressed MBP-ANX2 fusion protein as described in
Section 2. As shown in Fig. 3, 35S-ANX1 interacted with
MBP-ANX2 in the presence but not the absence of Ca2
ion (lane 4 vs. lane 2). When MBP was used in place of
MBP-ANX2, the interaction was not observed (lanes 1 and
3). The results demonstrate that ANX1 speci¢cally interacts
with ANX2 in a Ca2-dependent manner.
3.4. Re¢ning the interacting site between ANX1 and ANX2
ANX2 core domain contains four homologous repeat se-
quences (domains I, II, III, and IV) like other ANX family
proteins (Fig. 4). To obtain a re¢ned map for the interaction
between ANX1 and ANX2, DNA fragments encoding di¡er-
ent domains were cloned into the yeast two-hybrid vectors
and their interaction activities were compared by using the
expression of the reporter gene, lacZ. Fig. 4A shows the re-
sults when interaction between ANX11ÿ113 and di¡erent do-
mains of ANX2 was determined. The interaction was stronger
in the domain IV-containing peptides (domains II^IV, do-
mains III, IV and domain IV) compared to the other do-
main-containing peptides. Fig. 4B shows the interaction be-
tween ANX281ÿ338 and di¡erent ANX1 fragments. The
interaction of ANX281ÿ338 with domain I was stronger than
that with the N-terminal tail or domains II^IV. Fig. 4 dem-
onstrates that interaction between domain I of ANX1 and
domain IV of ANX2 was stronger compared to other combi-
nations.
4. Discussion
Although several physiological roles have been proposed
for ANX1, the mechanism by which it displays its functions
is still unknown. In this study, we attempted to identify pro-
teins interacting with ANX1. ANX1 interacted with ANX2 in
a Ca2-dependent manner, and the interaction occurred spe-
ci¢cally between domain I of ANX1 and domain IV of
ANX2. It is rather surprising that even though the four repeat
domains of ANX1 and ANX2 are homologous to each other
the interaction between the two domains is speci¢c. It is rea-
sonable to assume that the micro-heterogeneity between do-
main structures in£uences the binding. It is worth mentioning
that the N-terminal tail of ANX1 binds to ANX281ÿ338 to
some extent and enhances the binding of domain I (Fig. 4B).
The N-terminal tail of ANX1 is known to be important for
binding to another protein, S100C, and to be involved in the
physiological function [7]. The ¢rst 12 amino acids of ANX1
are reported to be the S100C-binding site. Both ANX2 and
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Fig. 4. Mapping of the interaction sites of ANX1 and ANX2. A:
Interaction of ANX11ÿ113 with di¡erent domains of ANX2. Various
mutants expressing di¡erent domains of ANX2 (left) were intro-
duced into the yeast cells expressing LexA-ANX11ÿ113, and their in-
teractions were compared by induction of L-galactosidase (right). B:
Mutants expressing di¡erent regions of ANX1 (left) were introduced
into the yeast cells expressing ANX281ÿ338, and their interactions
were compared by the induction of L-galactosidase (right). N, N-ter-
minal tail. Roman numerals represent the repeat domains of the
core domain. Arabic numbers represent the amino acid numbers.
The enzymatic activities are shown by the means þ S.D. (n = 4).
Fig. 3. Ca2-dependent interaction between ANX1 and ANX2. 35S-
ANX1, prepared by in vitro transcription and translation, was incu-
bated with bacterially expressed MBP (lanes 1 and 3) and MBP-
ANX2 (lanes 2 and 4) in the presence of EGTA (lanes 1 and 2) or
Ca2 (lanes 3 and 4). Amylose resin beads were added to each reac-
tion mixture and this was incubated to allow binding of the beads
to MBP. The bound proteins were eluted with maltose, analyzed by
SDS-PAGE and autoradiography.
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S100C interacts with ANX1 in a Ca2-dependent manner, but
their interaction sites on ANX1 are di¡erent. ANX2 binds to
domain I as well as to the N-terminal tail and S100C binds to
the N-terminal tail of ANX1.
Many proteins undergo a conformational change upon
Ca2 binding, which often results in the exposure of a hydro-
phobic region and interaction with other proteins [7,19]. Bind-
ing of Ca2 to domain IV of ANX2 may induce exposure of
the hydrophobic amino acids, which are likely to interact with
the K-helical structure of domain I of ANX1 [7]. It is known
that ANX family proteins form polymers by themselves or
with other proteins [20,21]. Whether the polymerization of
other ANX family proteins also involves the same type of
interaction is not known yet. It is likely to occur, at least in
some cases, because amino acid sequences of the repeat do-
mains are homologous and have the ability to bind Ca2.
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